Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Afpin Cl** is an oral botanical joint-health product marketed by Zuventus for the treatment of mild-to-moderate osteoarthritis. Each vegetarian capsule contains *Curcuma longa* rhizome extract formulated as CurQlife and *Boswellia serrata* extract formulated as Aflapin. The product is intended to support reduction of osteoarthritis-associated inflammation, pain, stiffness, and impaired joint function; the *Boswellia serrata* extract is associated with inhibition of the 5-lipoxygenase inflammatory pathway. ([zuventus.com](https://www.zuventus.com/products/afpin-cl))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Afpin Cl.